Institutional investors purchased a net $1.5 million shares of MEIP during the quarter ended June 2014 and now own 59.03% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRANKLIN ADVISERS, INC. Bought 466.1 Thousand shares of MEI Pharma Inc
SABBY CAPITAL LLC Bought 270.0 Thousand shares of MEI Pharma Inc
J.P. MORGAN SECURITIES LLC Bought 245.3 Thousand shares of MEI Pharma Inc